- Home
- FTI vs NBIX Comparison
FTI vs NBIX Comparison
Compare FTI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTI
- NBIX
- Stock Information
- Founded
- FTI 1884
- NBIX 1992
- Country
- FTI United States
- NBIX United States
- Employees
- FTI N/A
- NBIX N/A
- Industry
- FTI Metal Fabrications
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTI Industrials
- NBIX Health Care
- Exchange
- FTI Nasdaq
- NBIX Nasdaq
- Market Cap
- FTI 16.6B
- NBIX 14.4B
- IPO Year
- FTI N/A
- NBIX 1996
- Fundamental
- Price
- FTI $43.96
- NBIX $138.96
- Analyst Decision
- FTI Strong Buy
- NBIX Strong Buy
- Analyst Count
- FTI 11
- NBIX 18
- Target Price
- FTI $45.60
- NBIX $172.33
- AVG Volume (30 Days)
- FTI 3.9M
- NBIX 1.2M
- Earning Date
- FTI 10-23-2025
- NBIX 10-28-2025
- Dividend Yield
- FTI 0.46%
- NBIX N/A
- EPS Growth
- FTI 59.09
- NBIX 12.44
- EPS
- FTI 2.28
- NBIX 4.19
- Revenue
- FTI $9,803,000,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- FTI $10.39
- NBIX $23.68
- Revenue Next Year
- FTI $7.41
- NBIX $18.02
- P/E Ratio
- FTI $19.20
- NBIX $33.07
- Revenue Growth
- FTI 11.44
- NBIX 19.61
- 52 Week Low
- FTI $22.12
- NBIX $84.23
- 52 Week High
- FTI $44.34
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- FTI 65.21
- NBIX 41.83
- Support Level
- FTI $42.77
- NBIX $145.00
- Resistance Level
- FTI $44.34
- NBIX $148.84
- Average True Range (ATR)
- FTI 1.23
- NBIX 5.03
- MACD
- FTI 0.07
- NBIX -0.99
- Stochastic Oscillator
- FTI 89.28
- NBIX 10.68
About FTI TechnipFMC plc
TechnipFMC is the largest provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.